EUVIMEDObjevte EUVIMED
Systematische ÜbersichtMetaanalyseStudienprotokollOpen access

Safety and Efficacy of Neoadjuvant Therapy in Cholangiocarcinoma: Protocol for a Systematic Review and Meta-Analysis

Saikat Mandal iD, Arkadeep Dhali iD, Manideepa Maji iD, Suresh Vasan Venkatachalapathy, Amardeep Khanna, Dhanwant Gomez, Arvind Arora, Guruprasad Aithal iD

JMIR Research Protocols · 2026-06-10 · 15 · e84912-e84912

DOI: 10.2196/84912 ↗

At a glance

Systematische Übersicht in JMIR Research Protocols, published online on 2026-06-10. Written by Saikat Mandal and 7 co-authors. Institution: Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom. Major MEDLINE topics: Neoadjuvant Therapy, Cholangiocarcinoma, Bile Duct Neoplasms. 32 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Cholangiocarcinoma is an aggressive biliary tract malignancy with poor long-term survival and high recurrence rates even after apparently curative surgery. Although postoperative systemic therapy is incorporated into contemporary management, the role of neoadjuvant therapy remains uncertain because the available evidence is heterogeneous and largely observational and often mixes initially resectable and initially unresectable disease.

Objective

This protocol describes a systematic review and meta-analysis that will evaluate the safety and efficacy of neoadjuvant therapy followed by curative-intent surgery or liver transplantation in adults with cholangiocarcinoma. The review will address 2 clinically distinct pathways: initially resectable disease, in which neoadjuvant therapy is intended to improve oncological outcomes, and initially unresectable disease, in which treatment is intended to downstage disease or bridge patients to potentially curative surgery or transplantation.

Methods

The protocol has been prepared in accordance with the PRISMA-P (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols) 2015 statement and registered in PROSPERO. We will include randomized controlled trials and comparative nonrandomized studies evaluating neoadjuvant chemotherapy, chemoradiotherapy, immunotherapy, targeted therapy, or other preoperative antitumor therapy followed by curative-intent surgery or transplantation vs upfront surgery without preoperative systemic therapy. Single-arm studies, case reports, case series, and purely palliative cohorts will be excluded. The primary outcome will be overall survival analyzed as a time-to-event outcome using hazard ratios. Secondary outcomes will include recurrence-free survival, R0 resection, pathologic or radiologic complete response, conversion to operability among initially unresectable cohorts, and postoperative morbidity and mortality. Two reviewers will independently screen studies, extract data, and assess risk of bias using version 2 of the Cochrane risk-of-bias tool for randomized trials and the Risk of Bias in Nonrandomized Studies of Interventions tool for nonrandomized comparative studies. Random-effects meta-analysis; subgroup analyses; sensitivity analyses; assessment of reporting bias; and Grading of Recommendations Assessment, Development, and Evaluation (GRADE) certainty assessment will be undertaken where appropriate.

Results

Database searches were completed on February 27, 2026. Title and abstract screening and full-text eligibility assessment were completed in March 2026. Data extraction commenced in April 2026. Meta-analysis is scheduled for May 2026, risk-of-bias and GRADE assessments are scheduled for June 2026, final manuscript preparation is scheduled for August 2026, and submission of the completed systematic review manuscript is scheduled for September 2026.

Conclusions

This review will provide a methodologically explicit synthesis of comparative evidence on neoadjuvant therapy in cholangiocarcinoma while prespecifying separate analyses for initially resectable and initially unresectable disease. The findings are expected to inform future trial design, interpretation of emerging comparative evidence, and clinical decision-making in a setting where treatment intent varies substantially by resectability status.

Subjects

MeSH terms (MEDLINE)

Neoadjuvant TherapyCholangiocarcinomaBile Duct NeoplasmsHumansSystematic Reviews as TopicMeta-Analysis as TopicTreatment Outcome

Author keywords

bile duct cancerbiliary tract cancerchemotherapycholangiocarcinomaneoadjuvant chemotherapy

Authors and institutions

  • Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom.
  • W/E 1377, Nottingham Digestive Diseases Centre, E Floor, West Block, Queen's Medical Centre, Nottingham, NG7 2UH, United Kingdom, (+44) 0115 970 9900 (Ext 80616).
  • Sheffield University Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom.
  • Imperial College, London, United Kingdom.
  • Hull York Medical School, University of Hull, Hull, United Kingdom.

ORCID profiles: Saikat Mandal, Arkadeep Dhali, Manideepa Maji, Guruprasad Aithal

Cite

APA

Mandal, S., Dhali, A., Maji, M., Venkatachalapathy, S. V., Khanna, A., Gomez, D., Arora, A., & Aithal, G. (2026). Safety and Efficacy of Neoadjuvant Therapy in Cholangiocarcinoma: Protocol for a Systematic Review and Meta-Analysis. JMIR Research Protocols, 15, e84912-e84912. https://doi.org/10.2196/84912

Vancouver

Mandal S, Dhali A, Maji M, Venkatachalapathy SV, Khanna A, Gomez D, et al. Safety and Efficacy of Neoadjuvant Therapy in Cholangiocarcinoma: Protocol for a Systematic Review and Meta-Analysis. JMIR Research Protocols. 2026;15:e84912-e84912. doi:10.2196/84912

BibTeX
@article{Mandal2026,
  author = {Mandal, Saikat and Dhali, Arkadeep and Maji, Manideepa and Venkatachalapathy, Suresh Vasan and Khanna, Amardeep and Gomez, Dhanwant and Arora, Arvind and Aithal, Guruprasad},
  title = {Safety and Efficacy of Neoadjuvant Therapy in Cholangiocarcinoma: Protocol for a Systematic Review and Meta-Analysis},
  journal = {JMIR Research Protocols},
  year = {2026},
  volume = {15},
  pages = {e84912--e84912},
  doi = {10.2196/84912}
}
Start for free →